-
Are You Following Analysts On These Penny Stocks?
Friday, January 15, 2021 - 5:40pm | 1661Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. This year has gotten off to a strong start already. Many stocks, including penny stocks, are reaching new 52-week and all-time highs....
-
Piper Jaffray Initiates AcelRx Pharmaceuticals At Overweight, $7 PT
Thursday, March 24, 2011 - 7:45am | 25Read More...Piper Jaffray has initiated coverage on AcelRx Pharmaceuticals (NASDAQ: ACRX) with an Overweight rating and $7 price target.
